| 0 |
VAGINAL FLATULENCE |
39 |
0.3047 |
| 1 |
APPLICATION SITE BLEEDING |
45 |
0.1815 |
| 2 |
ORAL HERPES |
2367 |
0.1601 |
| 3 |
HERPES SIMPLEX |
708 |
0.1382 |
| 4 |
EYE OPERATION COMPLICATION |
20 |
0.1220 |
| 5 |
APPLICATION SITE ANAESTHESIA |
8 |
0.1143 |
| 6 |
APPLICATION SITE HYPOAESTHESIA |
19 |
0.1016 |
| 7 |
PIGMENTATION LIP |
8 |
0.0952 |
| 8 |
APPLICATION SITE SCAR |
103 |
0.0926 |
| 9 |
SCLERAL HYPERAEMIA |
60 |
0.0910 |
| 10 |
LIP HAEMORRHAGE |
88 |
0.0855 |
| 11 |
BURKHOLDERIA TEST POSITIVE |
10 |
0.0847 |
| 12 |
APPLICATION SITE SCAB |
165 |
0.0836 |
| 13 |
APPLICATION SITE HYPERAESTHESIA |
7 |
0.0745 |
| 14 |
APPLICATION SITE PARAESTHESIA |
88 |
0.0730 |
| 15 |
MULTIPLE DRUG THERAPY |
27 |
0.0701 |
| 16 |
APPLICATION SITE INFECTION |
32 |
0.0685 |
| 17 |
LIP INFECTION |
12 |
0.0674 |
| 18 |
MACULAR DEGENERATION |
589 |
0.0624 |
| 19 |
SEDATION COMPLICATION |
110 |
0.0614 |
| 20 |
LIP PAIN |
141 |
0.0594 |
| 21 |
DRUG ADMINISTRATION ERROR |
1793 |
0.0583 |
| 22 |
ACUTE PHOSPHATE NEPHROPATHY |
8 |
0.0541 |
| 23 |
LIP ERYTHEMA |
26 |
0.0496 |
| 24 |
APPLICATION SITE SWELLING |
208 |
0.0463 |
| 25 |
LIP EXFOLIATION |
48 |
0.0454 |
| 26 |
APPLICATION SITE INDURATION |
7 |
0.0452 |
| 27 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
601 |
0.0406 |
| 28 |
CHRONIC SINUSITIS |
113 |
0.0399 |
| 29 |
LIP BLISTER |
90 |
0.0396 |
| 30 |
INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT |
11 |
0.0394 |
| 31 |
LIP DISCOLOURATION |
36 |
0.0355 |
| 32 |
LIP DISORDER |
57 |
0.0348 |
| 33 |
CREATININE RENAL CLEARANCE DECREASED |
125 |
0.0348 |
| 34 |
LIP PRURITUS |
20 |
0.0335 |
| 35 |
APPLICATION SITE HAEMORRHAGE |
85 |
0.0335 |
| 36 |
FEMALE GENITAL TRACT FISTULA |
41 |
0.0325 |
| 37 |
FOREIGN BODY SENSATION IN EYES |
153 |
0.0324 |
| 38 |
CHEILITIS |
144 |
0.0318 |
| 39 |
PERIORBITAL PAIN |
10 |
0.0308 |
| 40 |
CHAPPED LIPS |
105 |
0.0294 |
| 41 |
INCORRECT DRUG ADMINISTRATION DURATION |
815 |
0.0289 |
| 42 |
INSTILLATION SITE PAIN |
61 |
0.0254 |
| 43 |
REACTION TO PRESERVATIVES |
16 |
0.0240 |
| 44 |
APPLICATION SITE PAIN |
450 |
0.0236 |
| 45 |
LIP DRY |
129 |
0.0235 |
| 46 |
APPLICATION SITE DRYNESS |
68 |
0.0234 |
| 47 |
CORNEAL EPITHELIUM DEFECT |
10 |
0.0224 |
| 48 |
RADICULOPATHY |
46 |
0.0221 |
| 49 |
APPLICATION SITE DISCOLOURATION |
82 |
0.0220 |
| 50 |
ABNORMAL SENSATION IN EYE |
80 |
0.0218 |
| 51 |
APPLICATION SITE IRRITATION |
230 |
0.0215 |
| 52 |
EYELID PAIN |
24 |
0.0212 |
| 53 |
PRODUCT COMPLAINT |
322 |
0.0212 |
| 54 |
INSTILLATION SITE PRURITUS |
7 |
0.0208 |
| 55 |
EYE DISCHARGE |
155 |
0.0208 |
| 56 |
APPLICATION SITE DISCHARGE |
21 |
0.0199 |
| 57 |
PROCTITIS |
40 |
0.0195 |
| 58 |
LIP SWELLING |
532 |
0.0195 |
| 59 |
EYE IRRITATION |
748 |
0.0190 |
| 60 |
INSTILLATION SITE IRRITATION |
11 |
0.0186 |
| 61 |
INSTILLATION SITE ERYTHEMA |
9 |
0.0184 |
| 62 |
LACRIMATION DECREASED |
7 |
0.0184 |
| 63 |
APPLICATION SITE REACTION |
122 |
0.0184 |
| 64 |
PRODUCT PACKAGE ASSOCIATED INJURY |
30 |
0.0179 |
| 65 |
CORNEAL TRANSPLANT |
10 |
0.0178 |
| 66 |
APPLICATION SITE INFLAMMATION |
19 |
0.0162 |
| 67 |
FOREIGN BODY IN EYE |
12 |
0.0161 |
| 68 |
EYELID EXFOLIATION |
9 |
0.0156 |
| 69 |
PARAESTHESIA ORAL |
174 |
0.0152 |
| 70 |
APPLICATION SITE VESICLES |
90 |
0.0150 |
| 71 |
EYELID IRRITATION |
26 |
0.0147 |
| 72 |
APPLICATION SITE PAPULES |
13 |
0.0138 |
| 73 |
BLOOD CALCIUM DECREASED |
131 |
0.0138 |
| 74 |
ERYTHEMA OF EYELID |
56 |
0.0137 |
| 75 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
39 |
0.0134 |
| 76 |
EYELIDS PRURITUS |
29 |
0.0130 |
| 77 |
OCULAR DISCOMFORT |
90 |
0.0128 |
| 78 |
ORAL DISCOMFORT |
147 |
0.0127 |
| 79 |
EYE PAIN |
494 |
0.0122 |
| 80 |
APPLICATION SITE EROSION |
14 |
0.0119 |
| 81 |
KERATITIS |
27 |
0.0117 |
| 82 |
APPLICATION SITE ULCER |
7 |
0.0110 |
| 83 |
APPLICATION SITE DISCOMFORT |
17 |
0.0110 |
| 84 |
CORNEAL ABRASION |
12 |
0.0108 |
| 85 |
CORNEAL DISORDER |
19 |
0.0107 |
| 86 |
APPLICATION SITE WARMTH |
12 |
0.0105 |
| 87 |
APPLICATION SITE ERYTHEMA |
248 |
0.0105 |
| 88 |
APPLICATION SITE BURN |
45 |
0.0102 |
| 89 |
SCAB |
91 |
0.0101 |
| 90 |
APPLICATION SITE EXFOLIATION |
37 |
0.0101 |
| 91 |
EYE ALLERGY |
11 |
0.0095 |
| 92 |
EYELID MARGIN CRUSTING |
17 |
0.0094 |
| 93 |
ORTHOSTATIC HYPOTENSION |
136 |
0.0094 |
| 94 |
OCULAR HYPERAEMIA |
303 |
0.0088 |
| 95 |
CONDITION AGGRAVATED |
1946 |
0.0087 |
| 96 |
INJECTION RELATED REACTION |
9 |
0.0084 |
| 97 |
INSTILLATION SITE REACTION |
9 |
0.0084 |
| 98 |
NEPHROCALCINOSIS |
8 |
0.0082 |
| 99 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
573 |
0.0080 |
| 100 |
LIP INJURY |
8 |
0.0080 |
| 101 |
EXPIRED PRODUCT ADMINISTERED |
212 |
0.0079 |
| 102 |
DRY EYE |
252 |
0.0079 |
| 103 |
LACRIMATION INCREASED |
174 |
0.0078 |
| 104 |
INTENTIONAL DRUG MISUSE |
163 |
0.0078 |
| 105 |
CONJUNCTIVITIS ALLERGIC |
8 |
0.0077 |
| 106 |
ASTHENOPIA |
32 |
0.0075 |
| 107 |
BLEPHARITIS |
21 |
0.0075 |
| 108 |
HAEMORRHAGIC DIATHESIS |
22 |
0.0072 |
| 109 |
PRODUCT DELIVERY MECHANISM ISSUE |
12 |
0.0071 |
| 110 |
DRUG INEFFECTIVE |
7546 |
0.0071 |
| 111 |
NONSPECIFIC REACTION |
29 |
0.0071 |
| 112 |
DRUG EFFECT DELAYED |
32 |
0.0070 |
| 113 |
PHOTOPHOBIA |
101 |
0.0070 |
| 114 |
VOLVULUS |
12 |
0.0069 |
| 115 |
ULCERATIVE KERATITIS |
15 |
0.0068 |
| 116 |
MOUTH SWELLING |
31 |
0.0068 |
| 117 |
INTESTINAL DILATATION |
7 |
0.0068 |
| 118 |
SUPERINFECTION |
8 |
0.0065 |
| 119 |
PUSTULE |
8 |
0.0065 |
| 120 |
PRODUCT CONTAINER ISSUE |
39 |
0.0064 |
| 121 |
EYELID DISORDER |
12 |
0.0064 |
| 122 |
OEDEMA MOUTH |
20 |
0.0063 |
| 123 |
EYE PRURITUS |
143 |
0.0063 |
| 124 |
SWELLING FACE |
334 |
0.0063 |
| 125 |
SCAR |
90 |
0.0063 |
| 126 |
HORDEOLUM |
17 |
0.0062 |
| 127 |
SEDATION |
120 |
0.0061 |
| 128 |
DRUG EFFECT LESS THAN EXPECTED |
29 |
0.0060 |
| 129 |
ASTIGMATISM |
7 |
0.0057 |
| 130 |
PROCEDURAL PAIN |
123 |
0.0057 |
| 131 |
HYPOAESTHESIA ORAL |
70 |
0.0056 |
| 132 |
EYELID OEDEMA |
59 |
0.0056 |
| 133 |
SUBILEUS |
10 |
0.0055 |
| 134 |
FACIAL PAIN |
39 |
0.0054 |
| 135 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
62 |
0.0054 |
| 136 |
HYPOAESTHESIA FACIAL |
8 |
0.0053 |
| 137 |
SKIN LACERATION |
41 |
0.0053 |
| 138 |
HYPERPHOSPHATAEMIA |
8 |
0.0053 |
| 139 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
74 |
0.0052 |
| 140 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
23 |
0.0052 |
| 141 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
13 |
0.0052 |
| 142 |
BLOOD CHLORIDE INCREASED |
7 |
0.0052 |
| 143 |
PRODUCT QUALITY ISSUE |
620 |
0.0051 |
| 144 |
VAGINAL DISCHARGE |
44 |
0.0051 |
| 145 |
EYE INFLAMMATION |
34 |
0.0050 |
| 146 |
CONJUNCTIVAL HYPERAEMIA |
14 |
0.0049 |
| 147 |
CORNEAL OEDEMA |
9 |
0.0048 |
| 148 |
EXPIRED DRUG ADMINISTERED |
24 |
0.0048 |
| 149 |
SWELLING OF EYELID |
17 |
0.0048 |
| 150 |
VITREOUS FLOATERS |
35 |
0.0048 |
| 151 |
EYE INFECTION |
40 |
0.0047 |
| 152 |
ARTHRITIS INFECTIVE |
17 |
0.0046 |
| 153 |
EYE OPERATION |
14 |
0.0046 |
| 154 |
APPLICATION SITE PRURITUS |
90 |
0.0045 |
| 155 |
APPETITE DISORDER |
22 |
0.0045 |
| 156 |
ORAL CANDIDIASIS |
44 |
0.0044 |
| 157 |
EYE SWELLING |
128 |
0.0043 |
| 158 |
DYSPHORIA |
19 |
0.0043 |
| 159 |
RENAL FUNCTION TEST ABNORMAL |
15 |
0.0043 |
| 160 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
139 |
0.0042 |
| 161 |
COGNITIVE DISORDER |
153 |
0.0041 |
| 162 |
VISION BLURRED |
443 |
0.0040 |
| 163 |
RENAL FAILURE CHRONIC |
31 |
0.0040 |
| 164 |
MEDICATION RESIDUE PRESENT |
19 |
0.0040 |
| 165 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
591 |
0.0040 |
| 166 |
NEUROGENIC BLADDER |
7 |
0.0039 |
| 167 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
406 |
0.0038 |
| 168 |
AORTIC ARTERIOSCLEROSIS |
8 |
0.0038 |
| 169 |
INTENTIONAL MISUSE |
7 |
0.0037 |
| 170 |
NEPHROGENIC ANAEMIA |
16 |
0.0036 |
| 171 |
SKIN WARM |
17 |
0.0036 |
| 172 |
EYE INJURY |
8 |
0.0036 |
| 173 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
36 |
0.0034 |
| 174 |
LIP OEDEMA |
12 |
0.0034 |
| 175 |
EYE DISORDER |
87 |
0.0033 |
| 176 |
INTRAOCULAR PRESSURE INCREASED |
36 |
0.0033 |
| 177 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
161 |
0.0033 |
| 178 |
CARTILAGE INJURY |
7 |
0.0033 |
| 179 |
CATARACT |
149 |
0.0033 |
| 180 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
12 |
0.0032 |
| 181 |
BRONCHIOLITIS |
9 |
0.0032 |
| 182 |
NORMOCHROMIC NORMOCYTIC ANAEMIA |
8 |
0.0032 |
| 183 |
EYELID PTOSIS |
25 |
0.0031 |
| 184 |
ORAL PAIN |
59 |
0.0031 |
| 185 |
BLOOD PHOSPHORUS DECREASED |
9 |
0.0031 |
| 186 |
PRODUCT USE COMPLAINT |
28 |
0.0031 |
| 187 |
TENDERNESS |
27 |
0.0031 |
| 188 |
PHOTOPSIA |
16 |
0.0030 |
| 189 |
CONJUNCTIVAL HAEMORRHAGE |
10 |
0.0030 |
| 190 |
RHINOVIRUS INFECTION |
7 |
0.0030 |
| 191 |
FREQUENT BOWEL MOVEMENTS |
58 |
0.0030 |
| 192 |
THERMAL BURN |
18 |
0.0030 |
| 193 |
BURNING SENSATION |
175 |
0.0030 |
| 194 |
GINGIVAL SWELLING |
11 |
0.0030 |
| 195 |
BLISTER |
127 |
0.0029 |
| 196 |
WOUND HAEMORRHAGE |
9 |
0.0029 |
| 197 |
INFUSION RELATED REACTION |
140 |
0.0029 |
| 198 |
BLOOD ALBUMIN DECREASED |
19 |
0.0029 |
| 199 |
ORAL MUCOSAL BLISTERING |
15 |
0.0028 |
| 200 |
HYPERSENSITIVITY |
420 |
0.0028 |
| 201 |
PERIORBITAL SWELLING |
8 |
0.0028 |
| 202 |
ANORECTAL DISCOMFORT |
13 |
0.0028 |
| 203 |
EAR PAIN |
43 |
0.0027 |
| 204 |
HISTIOCYTOSIS HAEMATOPHAGIC |
8 |
0.0027 |
| 205 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
19 |
0.0026 |
| 206 |
INJECTION SITE PAPULE |
10 |
0.0026 |
| 207 |
PNEUMONIA ASPIRATION |
52 |
0.0026 |
| 208 |
RESPIRATORY RATE DECREASED |
7 |
0.0026 |
| 209 |
BALANCE DISORDER |
189 |
0.0026 |
| 210 |
RHINITIS ALLERGIC |
9 |
0.0026 |
| 211 |
MOBILITY DECREASED |
146 |
0.0026 |
| 212 |
FACIAL PARESIS |
8 |
0.0026 |
| 213 |
CONSTIPATION |
423 |
0.0025 |
| 214 |
VISUAL ACUITY REDUCED |
78 |
0.0025 |
| 215 |
RENAL CYST |
17 |
0.0025 |
| 216 |
HAEMORRHAGIC ANAEMIA |
11 |
0.0025 |
| 217 |
PROCTALGIA |
13 |
0.0025 |
| 218 |
PURULENT DISCHARGE |
9 |
0.0025 |
| 219 |
LYMPHOCYTE COUNT DECREASED |
35 |
0.0024 |
| 220 |
SPINAL OSTEOARTHRITIS |
18 |
0.0024 |
| 221 |
PRE-EXISTING CONDITION IMPROVED |
14 |
0.0024 |
| 222 |
NAIL DISORDER |
15 |
0.0024 |
| 223 |
HAEMORRHOIDS |
39 |
0.0024 |
| 224 |
MADAROSIS |
26 |
0.0024 |
| 225 |
ILEUS |
23 |
0.0024 |
| 226 |
FAECALOMA |
10 |
0.0024 |
| 227 |
PERIORBITAL OEDEMA |
10 |
0.0023 |
| 228 |
CEREBRAL ATROPHY |
8 |
0.0023 |
| 229 |
APPLICATION SITE RASH |
29 |
0.0023 |
| 230 |
LOCAL SWELLING |
40 |
0.0023 |
| 231 |
PRODUCT PACKAGING QUANTITY ISSUE |
15 |
0.0023 |
| 232 |
NASAL DISCOMFORT |
15 |
0.0022 |
| 233 |
HYPERKERATOSIS |
10 |
0.0022 |
| 234 |
PRODUCT ADMINISTRATION ERROR |
29 |
0.0022 |
| 235 |
GINGIVITIS |
10 |
0.0022 |
| 236 |
DECUBITUS ULCER |
15 |
0.0022 |
| 237 |
ATELECTASIS |
18 |
0.0022 |
| 238 |
HIATUS HERNIA |
24 |
0.0022 |
| 239 |
GINGIVAL PAIN |
14 |
0.0021 |
| 240 |
BUNDLE BRANCH BLOCK LEFT |
8 |
0.0021 |
| 241 |
ACCIDENTAL EXPOSURE TO PRODUCT |
126 |
0.0021 |
| 242 |
DYSPEPSIA |
168 |
0.0021 |
| 243 |
HAEMORRHOIDAL HAEMORRHAGE |
9 |
0.0021 |
| 244 |
PRODUCT PACKAGING ISSUE |
15 |
0.0021 |
| 245 |
EYE MOVEMENT DISORDER |
12 |
0.0021 |
| 246 |
NEUTROPHIL COUNT INCREASED |
18 |
0.0021 |
| 247 |
SINUS HEADACHE |
11 |
0.0021 |
| 248 |
CONCOMITANT DISEASE AGGRAVATED |
11 |
0.0021 |
| 249 |
HYPERAESTHESIA |
15 |
0.0021 |
| 250 |
BLOOD MAGNESIUM DECREASED |
14 |
0.0021 |
| 251 |
PRODUCT RESIDUE PRESENT |
7 |
0.0021 |
| 252 |
INCORRECT PRODUCT STORAGE |
27 |
0.0021 |
| 253 |
COLITIS |
57 |
0.0020 |
| 254 |
IMPAIRED HEALING |
52 |
0.0020 |
| 255 |
GLAUCOMA |
32 |
0.0020 |
| 256 |
FAILURE TO THRIVE |
9 |
0.0020 |
| 257 |
BLINDNESS TRANSIENT |
12 |
0.0020 |
| 258 |
ORAL DISORDER |
12 |
0.0020 |
| 259 |
CONJUNCTIVITIS |
26 |
0.0020 |
| 260 |
RECTAL HAEMORRHAGE |
71 |
0.0020 |
| 261 |
ADVERSE REACTION |
21 |
0.0020 |
| 262 |
SNEEZING |
33 |
0.0019 |
| 263 |
DERMATITIS CONTACT |
17 |
0.0019 |
| 264 |
LEFT VENTRICULAR HYPERTROPHY |
7 |
0.0019 |
| 265 |
FEELING OF DESPAIR |
7 |
0.0019 |
| 266 |
RETINAL DETACHMENT |
14 |
0.0019 |
| 267 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
7 |
0.0019 |
| 268 |
BLOOD UREA INCREASED |
28 |
0.0019 |
| 269 |
INTESTINAL OBSTRUCTION |
54 |
0.0019 |
| 270 |
CLOSTRIDIUM DIFFICILE COLITIS |
16 |
0.0019 |
| 271 |
APHTHOUS ULCER |
10 |
0.0019 |
| 272 |
HYPOVOLAEMIA |
9 |
0.0019 |
| 273 |
PNEUMONIA BACTERIAL |
12 |
0.0018 |
| 274 |
ARTERIOSCLEROSIS CORONARY ARTERY |
10 |
0.0018 |
| 275 |
MULTIPLE ALLERGIES |
11 |
0.0018 |
| 276 |
SENSATION OF FOREIGN BODY |
12 |
0.0018 |
| 277 |
FLUID INTAKE REDUCED |
7 |
0.0018 |
| 278 |
NECK PAIN |
83 |
0.0018 |
| 279 |
THERAPEUTIC RESPONSE UNEXPECTED |
69 |
0.0018 |
| 280 |
VITAMIN D DECREASED |
13 |
0.0018 |
| 281 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
12 |
0.0018 |
| 282 |
LACERATION |
17 |
0.0018 |
| 283 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
72 |
0.0018 |
| 284 |
LOCALISED OEDEMA |
7 |
0.0018 |
| 285 |
PRODUCT ADMINISTRATION INTERRUPTED |
7 |
0.0018 |
| 286 |
BLEPHAROSPASM |
7 |
0.0018 |
| 287 |
VITAMIN D DEFICIENCY |
14 |
0.0018 |
| 288 |
HAEMATOCHEZIA |
76 |
0.0018 |
| 289 |
GASTROINTESTINAL PAIN |
15 |
0.0018 |
| 290 |
MACULAR OEDEMA |
8 |
0.0018 |
| 291 |
EYE HAEMORRHAGE |
20 |
0.0018 |
| 292 |
DECREASED INTEREST |
9 |
0.0018 |
| 293 |
NEUROLOGICAL SYMPTOM |
8 |
0.0018 |
| 294 |
ERYTHEMA |
294 |
0.0018 |
| 295 |
PROTEIN URINE PRESENT |
7 |
0.0017 |
| 296 |
BODY HEIGHT DECREASED |
17 |
0.0017 |
| 297 |
ANAL ABSCESS |
7 |
0.0017 |
| 298 |
COLITIS ULCERATIVE |
52 |
0.0017 |
| 299 |
SCOLIOSIS |
9 |
0.0017 |
| 300 |
RECALLED PRODUCT ADMINISTERED |
8 |
0.0017 |
| 301 |
OROPHARYNGEAL DISCOMFORT |
10 |
0.0017 |
| 302 |
VISUAL IMPAIRMENT |
157 |
0.0017 |
| 303 |
THINKING ABNORMAL |
27 |
0.0016 |
| 304 |
HOSPICE CARE |
12 |
0.0016 |
| 305 |
COLITIS ISCHAEMIC |
9 |
0.0016 |
| 306 |
DIVERTICULUM |
11 |
0.0016 |
| 307 |
HYDRONEPHROSIS |
10 |
0.0016 |
| 308 |
MALNUTRITION |
14 |
0.0016 |
| 309 |
OVERWEIGHT |
7 |
0.0016 |
| 310 |
SPUTUM DISCOLOURED |
12 |
0.0016 |
| 311 |
GASTRIC ULCER HAEMORRHAGE |
8 |
0.0016 |
| 312 |
RHINORRHOEA |
80 |
0.0016 |
| 313 |
TRICUSPID VALVE INCOMPETENCE |
10 |
0.0016 |
| 314 |
AMMONIA INCREASED |
7 |
0.0016 |
| 315 |
MENISCUS INJURY |
8 |
0.0016 |
| 316 |
BENIGN PROSTATIC HYPERPLASIA |
7 |
0.0016 |
| 317 |
GENERALISED ERYTHEMA |
9 |
0.0016 |
| 318 |
SPEECH DISORDER |
69 |
0.0016 |
| 319 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
7 |
0.0016 |
| 320 |
NEURALGIA |
30 |
0.0016 |
| 321 |
OESOPHAGITIS |
14 |
0.0016 |
| 322 |
CARPAL TUNNEL SYNDROME |
18 |
0.0016 |
| 323 |
TOOTHACHE |
23 |
0.0016 |
| 324 |
TONGUE DISORDER |
10 |
0.0016 |
| 325 |
BLOOD URIC ACID INCREASED |
7 |
0.0016 |
| 326 |
SKIN ULCER |
33 |
0.0015 |
| 327 |
IRRITABLE BOWEL SYNDROME |
24 |
0.0015 |
| 328 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
8 |
0.0015 |
| 329 |
SINUS CONGESTION |
17 |
0.0015 |
| 330 |
ECCHYMOSIS |
9 |
0.0015 |
| 331 |
WOUND |
31 |
0.0015 |
| 332 |
PRODUCT USE ISSUE |
219 |
0.0015 |
| 333 |
HYPERTRIGLYCERIDAEMIA |
7 |
0.0015 |
| 334 |
GLUCOSE TOLERANCE IMPAIRED |
7 |
0.0015 |
| 335 |
RENAL TUBULAR NECROSIS |
12 |
0.0015 |
| 336 |
HERPES VIRUS INFECTION |
7 |
0.0015 |
| 337 |
HAEMATOCRIT DECREASED |
26 |
0.0015 |
| 338 |
CYST |
15 |
0.0015 |
| 339 |
CATARACT OPERATION |
7 |
0.0015 |
| 340 |
FOOD ALLERGY |
7 |
0.0015 |
| 341 |
IMMUNOSUPPRESSION |
9 |
0.0015 |
| 342 |
POST PROCEDURAL INFECTION |
9 |
0.0015 |
| 343 |
PRODUCT USE IN UNAPPROVED INDICATION |
235 |
0.0014 |
| 344 |
HAEMOGLOBIN ABNORMAL |
7 |
0.0014 |
| 345 |
FEBRILE NEUTROPENIA |
73 |
0.0014 |
| 346 |
UPPER-AIRWAY COUGH SYNDROME |
9 |
0.0014 |
| 347 |
VISUAL FIELD DEFECT |
9 |
0.0014 |
| 348 |
GLOSSODYNIA |
24 |
0.0014 |
| 349 |
FLANK PAIN |
11 |
0.0014 |
| 350 |
HYPOPHAGIA |
28 |
0.0014 |
| 351 |
FEELING DRUNK |
9 |
0.0014 |
| 352 |
LARGE INTESTINE POLYP |
8 |
0.0014 |
| 353 |
PAPULE |
7 |
0.0014 |
| 354 |
HYPOXIA |
39 |
0.0014 |
| 355 |
SWOLLEN TONGUE |
37 |
0.0014 |
| 356 |
PSEUDOMONAS INFECTION |
9 |
0.0014 |
| 357 |
BLINDNESS UNILATERAL |
16 |
0.0014 |
| 358 |
SKIN INFECTION |
12 |
0.0014 |
| 359 |
DIVERTICULITIS |
31 |
0.0014 |
| 360 |
ABNORMAL FAECES |
9 |
0.0014 |
| 361 |
NEUROPATHY PERIPHERAL |
100 |
0.0014 |
| 362 |
APHONIA |
15 |
0.0014 |
| 363 |
MENTAL STATUS CHANGES |
32 |
0.0014 |
| 364 |
RED BLOOD CELL COUNT DECREASED |
32 |
0.0014 |
| 365 |
CELLULITIS |
58 |
0.0014 |
| 366 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
15 |
0.0014 |
| 367 |
MOUTH HAEMORRHAGE |
8 |
0.0014 |
| 368 |
STOMATITIS |
65 |
0.0014 |
| 369 |
HYPOALBUMINAEMIA |
8 |
0.0013 |
| 370 |
INFUSION SITE EXTRAVASATION |
7 |
0.0013 |
| 371 |
ARTHROPOD BITE |
8 |
0.0013 |
| 372 |
SENSORY DISTURBANCE |
19 |
0.0013 |
| 373 |
HYPOTENSION |
220 |
0.0013 |
| 374 |
WEIGHT DECREASED |
304 |
0.0013 |
| 375 |
SKIN REACTION |
15 |
0.0013 |
| 376 |
COAGULOPATHY |
19 |
0.0013 |
| 377 |
DRY MOUTH |
86 |
0.0013 |
| 378 |
URINE OUTPUT DECREASED |
10 |
0.0013 |
| 379 |
DRY THROAT |
11 |
0.0013 |
| 380 |
OSTEOARTHRITIS |
45 |
0.0013 |
| 381 |
FALL |
358 |
0.0013 |
| 382 |
TOOTH INFECTION |
14 |
0.0013 |
| 383 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
19 |
0.0013 |
| 384 |
IMPAIRED GASTRIC EMPTYING |
8 |
0.0013 |
| 385 |
PYELONEPHRITIS |
9 |
0.0013 |
| 386 |
SQUAMOUS CELL CARCINOMA |
10 |
0.0013 |
| 387 |
SKIN DISORDER |
34 |
0.0013 |
| 388 |
POLYP |
7 |
0.0013 |
| 389 |
DIPLOPIA |
27 |
0.0013 |
| 390 |
RASH PAPULAR |
25 |
0.0013 |
| 391 |
RENAL FAILURE ACUTE |
55 |
0.0013 |
| 392 |
PULMONARY MASS |
15 |
0.0013 |
| 393 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
28 |
0.0013 |
| 394 |
INTERVERTEBRAL DISC PROTRUSION |
24 |
0.0013 |
| 395 |
ONYCHOCLASIS |
7 |
0.0013 |
| 396 |
PAIN IN JAW |
31 |
0.0013 |
| 397 |
CANDIDA INFECTION |
16 |
0.0013 |
| 398 |
EMBOLISM |
9 |
0.0013 |
| 399 |
PRODUCT FORMULATION ISSUE |
7 |
0.0013 |
| 400 |
THERAPY CHANGE |
8 |
0.0013 |
| 401 |
POOR QUALITY PRODUCT ADMINISTERED |
7 |
0.0013 |
| 402 |
PELVIC FRACTURE |
8 |
0.0013 |
| 403 |
OBSESSIVE-COMPULSIVE DISORDER |
9 |
0.0013 |
| 404 |
GASTROOESOPHAGEAL REFLUX DISEASE |
81 |
0.0013 |
| 405 |
HAIR DISORDER |
10 |
0.0013 |
| 406 |
SKIN HAEMORRHAGE |
12 |
0.0013 |
| 407 |
EJECTION FRACTION DECREASED |
16 |
0.0013 |
| 408 |
PHOTOSENSITIVITY REACTION |
17 |
0.0013 |
| 409 |
DERMATITIS |
19 |
0.0013 |
| 410 |
ABDOMINAL PAIN |
236 |
0.0013 |
| 411 |
EXOSTOSIS |
9 |
0.0012 |
| 412 |
RHINITIS |
8 |
0.0012 |
| 413 |
BLINDNESS |
40 |
0.0012 |
| 414 |
DISSEMINATED INTRAVASCULAR COAGULATION |
15 |
0.0012 |
| 415 |
FACIAL PARALYSIS |
8 |
0.0012 |
| 416 |
ASPARTATE AMINOTRANSFERASE INCREASED |
55 |
0.0012 |
| 417 |
PAIN |
634 |
0.0012 |
| 418 |
DYSPHAGIA |
92 |
0.0012 |
| 419 |
ANAEMIA |
194 |
0.0012 |
| 420 |
LARGE INTESTINE PERFORATION |
7 |
0.0012 |
| 421 |
LOCALISED INFECTION |
24 |
0.0012 |
| 422 |
INTERVERTEBRAL DISC DEGENERATION |
10 |
0.0012 |
| 423 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
17 |
0.0012 |
| 424 |
GASTROENTERITIS VIRAL |
17 |
0.0012 |
| 425 |
CYSTITIS |
33 |
0.0012 |
| 426 |
SKIN DISCOLOURATION |
46 |
0.0012 |
| 427 |
IRON DEFICIENCY ANAEMIA |
9 |
0.0012 |
| 428 |
HAEMOGLOBIN DECREASED |
104 |
0.0012 |
| 429 |
MICTURITION URGENCY |
11 |
0.0012 |
| 430 |
POLLAKIURIA |
41 |
0.0012 |
| 431 |
MAJOR DEPRESSION |
7 |
0.0012 |
| 432 |
HYPERCHOLESTEROLAEMIA |
8 |
0.0012 |
| 433 |
SEASONAL ALLERGY |
12 |
0.0012 |
| 434 |
MASS |
14 |
0.0012 |
| 435 |
PROTEINURIA |
17 |
0.0012 |
| 436 |
DENTAL CARIES |
11 |
0.0012 |
| 437 |
LOW DENSITY LIPOPROTEIN INCREASED |
7 |
0.0012 |
| 438 |
RETCHING |
20 |
0.0012 |
| 439 |
URINARY TRACT INFECTION |
157 |
0.0012 |
| 440 |
UPPER RESPIRATORY TRACT INFECTION |
43 |
0.0012 |
| 441 |
JOINT RANGE OF MOTION DECREASED |
11 |
0.0012 |
| 442 |
BRAIN OEDEMA |
12 |
0.0012 |
| 443 |
SLEEP APNOEA SYNDROME |
19 |
0.0012 |
| 444 |
PHARMACEUTICAL PRODUCT COMPLAINT |
30 |
0.0012 |
| 445 |
ACUTE RESPIRATORY FAILURE |
17 |
0.0012 |
| 446 |
PRURITUS GENERALISED |
25 |
0.0012 |
| 447 |
PARAESTHESIA |
154 |
0.0012 |
| 448 |
SPINAL DISORDER |
9 |
0.0011 |
| 449 |
MUSCULOSKELETAL DISCOMFORT |
16 |
0.0011 |
| 450 |
CLOSTRIDIUM DIFFICILE INFECTION |
19 |
0.0011 |
| 451 |
IMMUNE SYSTEM DISORDER |
12 |
0.0011 |
| 452 |
HAIR COLOUR CHANGES |
13 |
0.0011 |
| 453 |
GASTRITIS |
25 |
0.0011 |
| 454 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
11 |
0.0011 |
| 455 |
HYPOTHYROIDISM |
28 |
0.0011 |
| 456 |
SMALL INTESTINAL OBSTRUCTION |
11 |
0.0011 |
| 457 |
SCIATICA |
13 |
0.0011 |
| 458 |
DRUG EFFECT INCOMPLETE |
41 |
0.0011 |
| 459 |
HIP FRACTURE |
29 |
0.0011 |
| 460 |
PHARYNGEAL OEDEMA |
17 |
0.0011 |
| 461 |
RESPIRATORY TRACT CONGESTION |
14 |
0.0011 |
| 462 |
SUPRAVENTRICULAR TACHYCARDIA |
9 |
0.0011 |
| 463 |
BACTERAEMIA |
10 |
0.0011 |
| 464 |
PYREXIA |
315 |
0.0011 |
| 465 |
RESTLESS LEGS SYNDROME |
17 |
0.0011 |
| 466 |
LYMPHADENOPATHY |
32 |
0.0011 |
| 467 |
MUSCULOSKELETAL CHEST PAIN |
14 |
0.0011 |
| 468 |
CONTUSION |
86 |
0.0011 |
| 469 |
BONE DISORDER |
18 |
0.0011 |
| 470 |
ALANINE AMINOTRANSFERASE INCREASED |
57 |
0.0011 |
| 471 |
FAECES DISCOLOURED |
20 |
0.0011 |
| 472 |
WOUND INFECTION |
8 |
0.0011 |
| 473 |
FULL BLOOD COUNT DECREASED |
17 |
0.0011 |
| 474 |
LEUKOCYTOSIS |
16 |
0.0011 |
| 475 |
PRURITUS |
298 |
0.0011 |
| 476 |
HYPOAESTHESIA |
135 |
0.0011 |
| 477 |
BLOOD POTASSIUM DECREASED |
27 |
0.0011 |
| 478 |
DYSGEUSIA |
70 |
0.0011 |
| 479 |
THROAT TIGHTNESS |
24 |
0.0011 |
| 480 |
FUNGAL INFECTION |
29 |
0.0011 |
| 481 |
NERVE COMPRESSION |
8 |
0.0011 |
| 482 |
EATING DISORDER |
19 |
0.0011 |
| 483 |
BLADDER DISORDER |
9 |
0.0011 |
| 484 |
EOSINOPHIL COUNT INCREASED |
7 |
0.0011 |
| 485 |
RASH PUSTULAR |
7 |
0.0011 |
| 486 |
ABDOMINAL DISTENSION |
88 |
0.0011 |
| 487 |
MITRAL VALVE INCOMPETENCE |
10 |
0.0011 |
| 488 |
GINGIVAL BLEEDING |
11 |
0.0011 |
| 489 |
BACK PAIN |
202 |
0.0011 |
| 490 |
BODY TEMPERATURE DECREASED |
9 |
0.0011 |
| 491 |
DISORIENTATION |
36 |
0.0010 |
| 492 |
DEHYDRATION |
116 |
0.0010 |
| 493 |
HUNGER |
9 |
0.0010 |
| 494 |
NODULE |
11 |
0.0010 |
| 495 |
RESPIRATORY FAILURE |
63 |
0.0010 |
| 496 |
RESPIRATORY DISTRESS |
24 |
0.0010 |
| 497 |
CHOLECYSTITIS |
10 |
0.0010 |
| 498 |
RASH MACULAR |
28 |
0.0010 |
| 499 |
HEAD DISCOMFORT |
14 |
0.0010 |
| 500 |
MUSCLE TIGHTNESS |
14 |
0.0010 |
| 501 |
ASCITES |
25 |
0.0010 |
| 502 |
PNEUMOTHORAX |
13 |
0.0010 |
| 503 |
OVARIAN CYST |
9 |
0.0010 |
| 504 |
SECOND PRIMARY MALIGNANCY |
7 |
0.0010 |
| 505 |
MIGRAINE |
76 |
0.0010 |
| 506 |
TOXICITY TO VARIOUS AGENTS |
134 |
0.0010 |
| 507 |
MYELOSUPPRESSION |
12 |
0.0010 |
| 508 |
PROCEDURAL COMPLICATION |
7 |
0.0010 |
| 509 |
CEREBRAL INFARCTION |
21 |
0.0010 |
| 510 |
DYSSTASIA |
25 |
0.0010 |
| 511 |
BLOOD PRESSURE SYSTOLIC INCREASED |
16 |
0.0010 |
| 512 |
PRODUCTIVE COUGH |
36 |
0.0010 |
| 513 |
LETHARGY |
49 |
0.0010 |
| 514 |
SWELLING |
75 |
0.0010 |
| 515 |
GAIT DISTURBANCE |
160 |
0.0010 |
| 516 |
QUALITY OF LIFE DECREASED |
11 |
0.0010 |
| 517 |
GASTROINTESTINAL INFECTION |
7 |
0.0010 |
| 518 |
SCRATCH |
7 |
0.0010 |
| 519 |
ELECTROLYTE IMBALANCE |
9 |
0.0010 |
| 520 |
DIZZINESS POSTURAL |
7 |
0.0010 |
| 521 |
OSTEOPENIA |
13 |
0.0010 |
| 522 |
DRUG HYPERSENSITIVITY |
162 |
0.0010 |
| 523 |
EAR DISCOMFORT |
8 |
0.0010 |
| 524 |
HYPERKALAEMIA |
28 |
0.0010 |
| 525 |
CARDIOMEGALY |
11 |
0.0010 |
| 526 |
SINUSITIS |
82 |
0.0010 |
| 527 |
RASH |
333 |
0.0010 |
| 528 |
HEAD INJURY |
25 |
0.0010 |
| 529 |
HALLUCINATION, VISUAL |
16 |
0.0010 |
| 530 |
NEPHROPATHY |
8 |
0.0010 |
| 531 |
VERTIGO |
50 |
0.0010 |
| 532 |
TENDONITIS |
13 |
0.0010 |
| 533 |
MUSCLE TWITCHING |
19 |
0.0010 |
| 534 |
MUSCLE STRAIN |
7 |
0.0010 |
| 535 |
FIBROMYALGIA |
18 |
0.0010 |
| 536 |
SKIN LESION |
21 |
0.0010 |
| 537 |
BLOOD SODIUM DECREASED |
15 |
0.0010 |
| 538 |
RESPIRATORY RATE INCREASED |
7 |
0.0010 |
| 539 |
ALTERED STATE OF CONSCIOUSNESS |
16 |
0.0010 |
| 540 |
IMPAIRED WORK ABILITY |
18 |
0.0010 |
| 541 |
THIRST |
14 |
0.0010 |
| 542 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
35 |
0.0010 |
| 543 |
MUSCULOSKELETAL PAIN |
46 |
0.0010 |
| 544 |
BLOOD CALCIUM INCREASED |
7 |
0.0010 |
| 545 |
HYPERLIPIDAEMIA |
10 |
0.0010 |
| 546 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
19 |
0.0010 |
| 547 |
PHARYNGITIS |
10 |
0.0010 |
| 548 |
BLOOD BILIRUBIN INCREASED |
22 |
0.0010 |
| 549 |
PARANOIA |
14 |
0.0010 |
| 550 |
PALLOR |
22 |
0.0010 |
| 551 |
OEDEMA |
41 |
0.0010 |
| 552 |
WHITE BLOOD CELL COUNT INCREASED |
31 |
0.0010 |
| 553 |
SKIN FISSURES |
11 |
0.0009 |
| 554 |
ASPIRATION |
8 |
0.0009 |
| 555 |
GROIN PAIN |
7 |
0.0009 |
| 556 |
HYPONATRAEMIA |
44 |
0.0009 |
| 557 |
TACHYPNOEA |
10 |
0.0009 |
| 558 |
VIRAL INFECTION |
24 |
0.0009 |
| 559 |
HYPOMAGNESAEMIA |
10 |
0.0009 |
| 560 |
MALAISE |
347 |
0.0009 |
| 561 |
DYSURIA |
29 |
0.0009 |
| 562 |
THERAPEUTIC RESPONSE DECREASED |
44 |
0.0009 |
| 563 |
IMPAIRED DRIVING ABILITY |
9 |
0.0009 |
| 564 |
THROMBOCYTOPENIA |
83 |
0.0009 |
| 565 |
SINUS DISORDER |
15 |
0.0009 |
| 566 |
ANKLE FRACTURE |
12 |
0.0009 |
| 567 |
HAEMATEMESIS |
20 |
0.0009 |
| 568 |
ANOREXIA |
12 |
0.0009 |
| 569 |
PLATELET COUNT DECREASED |
80 |
0.0009 |
| 570 |
OROPHARYNGEAL PAIN |
69 |
0.0009 |
| 571 |
BLOOD CREATININE INCREASED |
51 |
0.0009 |
| 572 |
PRODUCT STORAGE ERROR |
44 |
0.0009 |
| 573 |
SKIN CANCER |
16 |
0.0009 |
| 574 |
JOINT INJURY |
16 |
0.0009 |
| 575 |
HEADACHE |
475 |
0.0009 |
| 576 |
ASTHENIA |
282 |
0.0009 |
| 577 |
NEPHROLITHIASIS |
33 |
0.0009 |
| 578 |
MUSCULOSKELETAL STIFFNESS |
66 |
0.0009 |
| 579 |
NASAL CONGESTION |
41 |
0.0009 |
| 580 |
HAEMATURIA |
27 |
0.0009 |
| 581 |
INJECTION SITE MASS |
26 |
0.0009 |
| 582 |
TOOTH ABSCESS |
8 |
0.0009 |
| 583 |
CHILLS |
88 |
0.0009 |
| 584 |
LOWER LIMB FRACTURE |
13 |
0.0009 |
| 585 |
TREMOR |
127 |
0.0009 |
| 586 |
HYPERSOMNIA |
21 |
0.0009 |
| 587 |
TRANSFUSION |
8 |
0.0009 |
| 588 |
INFLAMMATION |
35 |
0.0009 |
| 589 |
PANCYTOPENIA |
40 |
0.0009 |
| 590 |
DRY SKIN |
88 |
0.0009 |
| 591 |
INSOMNIA |
201 |
0.0009 |
| 592 |
NAUSEA |
577 |
0.0009 |
| 593 |
COVID-19 PNEUMONIA |
8 |
0.0009 |
| 594 |
HYPERCALCAEMIA |
9 |
0.0009 |
| 595 |
GASTROINTESTINAL HAEMORRHAGE |
67 |
0.0009 |
| 596 |
DIZZINESS |
366 |
0.0009 |
| 597 |
GOUT |
13 |
0.0009 |
| 598 |
ANAPHYLACTIC REACTION |
37 |
0.0009 |
| 599 |
MUSCULAR WEAKNESS |
83 |
0.0009 |
| 600 |
SKIN IRRITATION |
35 |
0.0009 |
| 601 |
MOVEMENT DISORDER |
24 |
0.0009 |
| 602 |
MUSCLE SPASMS |
135 |
0.0009 |
| 603 |
DIARRHOEA |
449 |
0.0009 |
| 604 |
MYALGIA |
124 |
0.0009 |
| 605 |
SECRETION DISCHARGE |
8 |
0.0009 |
| 606 |
WHEEZING |
39 |
0.0009 |
| 607 |
DRUG-INDUCED LIVER INJURY |
18 |
0.0009 |
| 608 |
COORDINATION ABNORMAL |
11 |
0.0009 |
| 609 |
PNEUMONIA |
225 |
0.0009 |
| 610 |
FEEDING DISORDER |
12 |
0.0009 |
| 611 |
OEDEMA PERIPHERAL |
94 |
0.0009 |
| 612 |
DELIRIUM |
24 |
0.0009 |
| 613 |
ADVERSE DRUG REACTION |
58 |
0.0009 |
| 614 |
INTESTINAL PERFORATION |
8 |
0.0009 |
| 615 |
IMMUNODEFICIENCY |
9 |
0.0009 |
| 616 |
OBSTRUCTIVE AIRWAYS DISORDER |
8 |
0.0009 |
| 617 |
ILL-DEFINED DISORDER |
31 |
0.0009 |
| 618 |
THROAT IRRITATION |
31 |
0.0009 |
| 619 |
PERIPHERAL COLDNESS |
10 |
0.0009 |
| 620 |
ABDOMINAL DISCOMFORT |
116 |
0.0009 |
| 621 |
DYSPHONIA |
41 |
0.0009 |
| 622 |
BLOOD URINE PRESENT |
14 |
0.0009 |
| 623 |
BLOOD PRESSURE INCREASED |
109 |
0.0009 |
| 624 |
HYPOCALCAEMIA |
13 |
0.0009 |
| 625 |
DECREASED APPETITE |
157 |
0.0009 |
| 626 |
LUNG INFILTRATION |
7 |
0.0009 |
| 627 |
FEELING COLD |
20 |
0.0009 |
| 628 |
HAEMORRHAGE |
72 |
0.0009 |
| 629 |
CONFUSIONAL STATE |
116 |
0.0009 |
| 630 |
RASH MACULO-PAPULAR |
15 |
0.0009 |
| 631 |
PELVIC PAIN |
13 |
0.0009 |
| 632 |
CYTOKINE RELEASE SYNDROME |
7 |
0.0009 |
| 633 |
AGRANULOCYTOSIS |
12 |
0.0009 |
| 634 |
BLOOD GLUCOSE FLUCTUATION |
8 |
0.0009 |
| 635 |
HAEMOPTYSIS |
20 |
0.0009 |
| 636 |
INTERNATIONAL NORMALISED RATIO INCREASED |
23 |
0.0009 |
| 637 |
LOWER RESPIRATORY TRACT INFECTION |
28 |
0.0009 |
| 638 |
NIGHTMARE |
25 |
0.0008 |
| 639 |
EAR INFECTION |
17 |
0.0008 |
| 640 |
HYPOKALAEMIA |
31 |
0.0008 |
| 641 |
AMNESIA |
47 |
0.0008 |
| 642 |
SKIN EXFOLIATION |
53 |
0.0008 |
| 643 |
BURSITIS |
7 |
0.0008 |
| 644 |
MENTAL DISORDER |
30 |
0.0008 |
| 645 |
CHEST PAIN |
131 |
0.0008 |
| 646 |
OFF LABEL USE |
490 |
0.0008 |
| 647 |
HEPATIC FUNCTION ABNORMAL |
24 |
0.0008 |
| 648 |
RIB FRACTURE |
14 |
0.0008 |
| 649 |
SEPTIC SHOCK |
28 |
0.0008 |
| 650 |
FATIGUE |
515 |
0.0008 |
| 651 |
ARTHRITIS |
53 |
0.0008 |
| 652 |
URTICARIA |
108 |
0.0008 |
| 653 |
BLOOD PRESSURE FLUCTUATION |
17 |
0.0008 |
| 654 |
DYSKINESIA |
28 |
0.0008 |
| 655 |
APHASIA |
21 |
0.0008 |
| 656 |
DYSARTHRIA |
26 |
0.0008 |
| 657 |
COUGH |
181 |
0.0008 |
| 658 |
WHITE BLOOD CELL COUNT DECREASED |
72 |
0.0008 |
| 659 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0008 |
| 660 |
PERICARDIAL EFFUSION |
15 |
0.0008 |
| 661 |
FEAR |
20 |
0.0008 |
| 662 |
IMPAIRED QUALITY OF LIFE |
8 |
0.0008 |
| 663 |
MUCOSAL INFLAMMATION |
17 |
0.0008 |
| 664 |
HAIR TEXTURE ABNORMAL |
10 |
0.0008 |
| 665 |
DEEP VEIN THROMBOSIS |
47 |
0.0008 |
| 666 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
35 |
0.0008 |
| 667 |
GASTRIC DISORDER |
28 |
0.0008 |
| 668 |
JAUNDICE |
19 |
0.0008 |
| 669 |
DEMENTIA |
17 |
0.0008 |
| 670 |
NASOPHARYNGITIS |
116 |
0.0008 |
| 671 |
SLEEP DISORDER |
43 |
0.0008 |
| 672 |
RASH GENERALISED |
21 |
0.0008 |
| 673 |
ECONOMIC PROBLEM |
12 |
0.0008 |
| 674 |
THYROID DISORDER |
10 |
0.0008 |
| 675 |
OXYGEN SATURATION DECREASED |
34 |
0.0008 |
| 676 |
MULTI-ORGAN FAILURE |
14 |
0.0008 |
| 677 |
INJECTION SITE INDURATION |
9 |
0.0008 |
| 678 |
GASTRIC ULCER |
13 |
0.0008 |
| 679 |
PRODUCT SUBSTITUTION ISSUE |
39 |
0.0008 |
| 680 |
RASH ERYTHEMATOUS |
27 |
0.0008 |
| 681 |
INTERSTITIAL LUNG DISEASE |
30 |
0.0008 |
| 682 |
HYPERTHYROIDISM |
9 |
0.0008 |
| 683 |
BRONCHITIS |
50 |
0.0008 |
| 684 |
BLOOD TRIGLYCERIDES INCREASED |
12 |
0.0008 |
| 685 |
INJECTION SITE PAIN |
178 |
0.0008 |
| 686 |
FLATULENCE |
36 |
0.0008 |
| 687 |
HERNIA |
12 |
0.0008 |
| 688 |
PAIN IN EXTREMITY |
197 |
0.0008 |
| 689 |
SYNCOPE |
66 |
0.0008 |
| 690 |
JOINT SWELLING |
75 |
0.0008 |
| 691 |
PULMONARY HYPERTENSION |
14 |
0.0008 |
| 692 |
JOINT STIFFNESS |
17 |
0.0008 |
| 693 |
TRANSIENT ISCHAEMIC ATTACK |
23 |
0.0008 |
| 694 |
HALLUCINATION |
46 |
0.0008 |
| 695 |
ECZEMA |
19 |
0.0008 |
| 696 |
EUPHORIC MOOD |
7 |
0.0008 |
| 697 |
DYSPNOEA |
361 |
0.0008 |
| 698 |
URINARY RETENTION |
21 |
0.0008 |
| 699 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
7 |
0.0008 |
| 700 |
AGEUSIA |
16 |
0.0008 |
| 701 |
NERVOUSNESS |
36 |
0.0008 |
| 702 |
SEPSIS |
71 |
0.0008 |
| 703 |
DISEASE PROGRESSION |
70 |
0.0008 |
| 704 |
BACTERIAL INFECTION |
11 |
0.0008 |
| 705 |
FACE OEDEMA |
11 |
0.0008 |
| 706 |
STRESS |
44 |
0.0008 |
| 707 |
CHOLELITHIASIS |
21 |
0.0008 |
| 708 |
HEART RATE INCREASED |
62 |
0.0008 |
| 709 |
VOMITING |
285 |
0.0008 |
| 710 |
GASTROENTERITIS |
9 |
0.0008 |
| 711 |
PULMONARY CONGESTION |
8 |
0.0008 |
| 712 |
INFLUENZA |
63 |
0.0008 |
| 713 |
ABDOMINAL PAIN LOWER |
16 |
0.0008 |
| 714 |
NOCTURIA |
7 |
0.0008 |
| 715 |
PARALYSIS |
9 |
0.0008 |
| 716 |
ARTHRALGIA |
243 |
0.0008 |
| 717 |
NEUTROPHIL COUNT DECREASED |
23 |
0.0007 |
| 718 |
INCORRECT DOSE ADMINISTERED |
114 |
0.0007 |
| 719 |
TOXIC EPIDERMAL NECROLYSIS |
9 |
0.0007 |
| 720 |
BODY TEMPERATURE INCREASED |
13 |
0.0007 |
| 721 |
CEREBROVASCULAR ACCIDENT |
109 |
0.0007 |
| 722 |
MELAENA |
14 |
0.0007 |
| 723 |
TINNITUS |
28 |
0.0007 |
| 724 |
ANXIETY |
178 |
0.0007 |
| 725 |
HYPERTENSION |
127 |
0.0007 |
| 726 |
FEELING HOT |
38 |
0.0007 |
| 727 |
LIVER FUNCTION TEST INCREASED |
11 |
0.0007 |
| 728 |
HEPATIC STEATOSIS |
11 |
0.0007 |
| 729 |
IRRITABILITY |
38 |
0.0007 |
| 730 |
ROTATOR CUFF SYNDROME |
8 |
0.0007 |
| 731 |
TUBULOINTERSTITIAL NEPHRITIS |
11 |
0.0007 |
| 732 |
DELUSION |
9 |
0.0007 |
| 733 |
PANIC ATTACK |
22 |
0.0007 |
| 734 |
ACUTE MYELOID LEUKAEMIA |
9 |
0.0007 |
| 735 |
MOUTH ULCERATION |
12 |
0.0007 |
| 736 |
HYPERGLYCAEMIA |
22 |
0.0007 |
| 737 |
INJECTION SITE WARMTH |
13 |
0.0007 |
| 738 |
FEELING ABNORMAL |
150 |
0.0007 |
| 739 |
END STAGE RENAL DISEASE |
12 |
0.0007 |
| 740 |
DISCOMFORT |
32 |
0.0007 |
| 741 |
LIMB DISCOMFORT |
18 |
0.0007 |
| 742 |
RESPIRATORY TRACT INFECTION |
14 |
0.0007 |
| 743 |
ANGER |
21 |
0.0007 |
| 744 |
BASAL CELL CARCINOMA |
9 |
0.0007 |
| 745 |
LIMB INJURY |
15 |
0.0007 |
| 746 |
INTENTIONAL PRODUCT MISUSE |
50 |
0.0007 |
| 747 |
BRADYCARDIA |
32 |
0.0007 |
| 748 |
INJECTION SITE PRURITUS |
38 |
0.0007 |
| 749 |
C-REACTIVE PROTEIN INCREASED |
20 |
0.0007 |
| 750 |
PALPITATIONS |
68 |
0.0007 |
| 751 |
HOT FLUSH |
40 |
0.0007 |
| 752 |
INJECTION SITE BRUISING |
43 |
0.0007 |
| 753 |
ABDOMINAL PAIN UPPER |
116 |
0.0007 |
| 754 |
SEIZURE |
60 |
0.0007 |
| 755 |
OSTEOMYELITIS |
11 |
0.0007 |
| 756 |
POST PROCEDURAL HAEMORRHAGE |
7 |
0.0007 |
| 757 |
SOMNOLENCE |
115 |
0.0007 |
| 758 |
KIDNEY INFECTION |
11 |
0.0007 |
| 759 |
MENTAL IMPAIRMENT |
14 |
0.0007 |
| 760 |
RENAL IMPAIRMENT |
46 |
0.0007 |
| 761 |
OSTEOPOROSIS |
24 |
0.0007 |
| 762 |
ATAXIA |
7 |
0.0007 |
| 763 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
10 |
0.0007 |
| 764 |
PLEURAL EFFUSION |
35 |
0.0007 |
| 765 |
CHRONIC KIDNEY DISEASE |
48 |
0.0007 |
| 766 |
ADVERSE EVENT |
52 |
0.0007 |
| 767 |
FOOT FRACTURE |
11 |
0.0007 |
| 768 |
ATRIAL FIBRILLATION |
55 |
0.0007 |
| 769 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
15 |
0.0007 |
| 770 |
MIDDLE INSOMNIA |
10 |
0.0007 |
| 771 |
GAIT INABILITY |
15 |
0.0007 |
| 772 |
ARTHROPATHY |
31 |
0.0007 |
| 773 |
ACUTE KIDNEY INJURY |
80 |
0.0007 |
| 774 |
THERAPY INTERRUPTED |
22 |
0.0007 |
| 775 |
GASTRIC HAEMORRHAGE |
7 |
0.0007 |
| 776 |
NIGHT SWEATS |
17 |
0.0007 |
| 777 |
MEDICATION ERROR |
31 |
0.0007 |
| 778 |
PRODUCT DOSE OMISSION |
45 |
0.0007 |
| 779 |
DEVICE RELATED INFECTION |
9 |
0.0007 |
| 780 |
LOSS OF CONSCIOUSNESS |
72 |
0.0007 |
| 781 |
ERUCTATION |
9 |
0.0007 |
| 782 |
DEVICE USE ISSUE |
7 |
0.0007 |
| 783 |
PERIPHERAL SWELLING |
80 |
0.0007 |
| 784 |
PLASMA CELL MYELOMA |
21 |
0.0007 |
| 785 |
ACUTE HEPATIC FAILURE |
7 |
0.0007 |
| 786 |
MYDRIASIS |
7 |
0.0007 |
| 787 |
PLATELET COUNT INCREASED |
7 |
0.0007 |
| 788 |
ELECTROCARDIOGRAM QT PROLONGED |
19 |
0.0007 |
| 789 |
HYPOGLYCAEMIA |
27 |
0.0007 |
| 790 |
EPISTAXIS |
41 |
0.0007 |
| 791 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
13 |
0.0007 |
| 792 |
BLOOD GLUCOSE ABNORMAL |
10 |
0.0007 |
| 793 |
NO THERAPEUTIC RESPONSE |
8 |
0.0007 |
| 794 |
INJECTION SITE HAEMORRHAGE |
40 |
0.0007 |
| 795 |
METASTASES TO LIVER |
9 |
0.0007 |
| 796 |
CHOKING |
10 |
0.0007 |
| 797 |
ASTHMA |
52 |
0.0006 |
| 798 |
AGITATION |
41 |
0.0006 |
| 799 |
SUBDURAL HAEMATOMA |
8 |
0.0006 |
| 800 |
INFECTION |
72 |
0.0006 |
| 801 |
LIVER FUNCTION TEST ABNORMAL |
17 |
0.0006 |
| 802 |
DEPRESSED MOOD |
27 |
0.0006 |
| 803 |
GASTROINTESTINAL DISORDER |
39 |
0.0006 |
| 804 |
RENAL FAILURE |
76 |
0.0006 |
| 805 |
EXPOSURE DURING PREGNANCY |
31 |
0.0006 |
| 806 |
PRODUCT DISPENSING ERROR |
9 |
0.0006 |
| 807 |
CHEST DISCOMFORT |
52 |
0.0006 |
| 808 |
BEDRIDDEN |
7 |
0.0006 |
| 809 |
RASH PRURITIC |
27 |
0.0006 |
| 810 |
SPINAL FRACTURE |
10 |
0.0006 |
| 811 |
GENERAL PHYSICAL HEALTH DETERIORATION |
54 |
0.0006 |
| 812 |
TACHYCARDIA |
46 |
0.0006 |
| 813 |
FLUSHING |
56 |
0.0006 |
| 814 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
12 |
0.0006 |
| 815 |
HIP ARTHROPLASTY |
7 |
0.0006 |
| 816 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
12 |
0.0006 |
| 817 |
POST PROCEDURAL COMPLICATION |
10 |
0.0006 |
| 818 |
MULTIPLE SCLEROSIS |
25 |
0.0006 |
| 819 |
ROAD TRAFFIC ACCIDENT |
21 |
0.0006 |
| 820 |
FLUID OVERLOAD |
9 |
0.0006 |
| 821 |
INJECTION SITE RASH |
14 |
0.0006 |
| 822 |
BLOOD CHOLESTEROL INCREASED |
23 |
0.0006 |
| 823 |
SHOCK |
11 |
0.0006 |
| 824 |
DRUG EFFECT DECREASED |
33 |
0.0006 |
| 825 |
THERAPY CESSATION |
24 |
0.0006 |
| 826 |
THROMBOSIS |
41 |
0.0006 |
| 827 |
ABASIA |
15 |
0.0006 |
| 828 |
INFLUENZA LIKE ILLNESS |
43 |
0.0006 |
| 829 |
HEART RATE IRREGULAR |
12 |
0.0006 |
| 830 |
CEREBRAL HAEMORRHAGE |
18 |
0.0006 |
| 831 |
ALOPECIA |
99 |
0.0006 |
| 832 |
POOR QUALITY SLEEP |
10 |
0.0006 |
| 833 |
HYPERHIDROSIS |
65 |
0.0006 |
| 834 |
INTENTIONAL DOSE OMISSION |
7 |
0.0006 |
| 835 |
CRYING |
19 |
0.0006 |
| 836 |
APATHY |
7 |
0.0006 |
| 837 |
HERPES ZOSTER |
28 |
0.0006 |
| 838 |
BLOOD POTASSIUM INCREASED |
8 |
0.0006 |
| 839 |
DRUG LEVEL INCREASED |
8 |
0.0006 |
| 840 |
DISTURBANCE IN ATTENTION |
27 |
0.0006 |
| 841 |
ILLNESS |
29 |
0.0006 |
| 842 |
RHEUMATOID ARTHRITIS |
53 |
0.0006 |
| 843 |
DRUG TOXICITY |
8 |
0.0006 |
| 844 |
DYSPNOEA EXERTIONAL |
17 |
0.0006 |
| 845 |
DEVICE MALFUNCTION |
28 |
0.0006 |
| 846 |
MYELODYSPLASTIC SYNDROME |
7 |
0.0006 |
| 847 |
GALLBLADDER DISORDER |
9 |
0.0006 |
| 848 |
NERVOUS SYSTEM DISORDER |
16 |
0.0006 |
| 849 |
MEMORY IMPAIRMENT |
66 |
0.0006 |
| 850 |
MOOD SWINGS |
16 |
0.0006 |
| 851 |
OBESITY |
7 |
0.0006 |
| 852 |
UPPER LIMB FRACTURE |
10 |
0.0006 |
| 853 |
SURGERY |
24 |
0.0006 |
| 854 |
HEART RATE DECREASED |
17 |
0.0006 |
| 855 |
STEVENS-JOHNSON SYNDROME |
11 |
0.0006 |
| 856 |
DEPRESSION |
113 |
0.0006 |
| 857 |
ACNE |
38 |
0.0006 |
| 858 |
CORONARY ARTERY OCCLUSION |
7 |
0.0006 |
| 859 |
EMOTIONAL DISORDER |
15 |
0.0006 |
| 860 |
SUICIDAL IDEATION |
43 |
0.0006 |
| 861 |
UNEVALUABLE EVENT |
37 |
0.0006 |
| 862 |
INTENTIONAL PRODUCT USE ISSUE |
37 |
0.0006 |
| 863 |
DRUG INTERACTION |
74 |
0.0006 |
| 864 |
THERAPY NON-RESPONDER |
17 |
0.0006 |
| 865 |
WEIGHT INCREASED |
100 |
0.0006 |
| 866 |
BONE PAIN |
27 |
0.0006 |
| 867 |
HEPATIC CIRRHOSIS |
8 |
0.0006 |
| 868 |
COMA |
22 |
0.0006 |
| 869 |
BLOOD PRESSURE DECREASED |
30 |
0.0006 |
| 870 |
DRUG INTOLERANCE |
41 |
0.0006 |
| 871 |
CARDIAC FAILURE CONGESTIVE |
41 |
0.0006 |
| 872 |
LEUKOPENIA |
22 |
0.0006 |
| 873 |
EPILEPSY |
13 |
0.0005 |
| 874 |
DRUG DOSE OMISSION |
91 |
0.0005 |
| 875 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
18 |
0.0005 |
| 876 |
RENAL DISORDER |
21 |
0.0005 |
| 877 |
MUSCULOSKELETAL DISORDER |
9 |
0.0005 |
| 878 |
LABORATORY TEST ABNORMAL |
13 |
0.0005 |
| 879 |
PULMONARY EMBOLISM |
45 |
0.0005 |
| 880 |
PNEUMONITIS |
11 |
0.0005 |
| 881 |
COLD SWEAT |
8 |
0.0005 |
| 882 |
INJURY |
34 |
0.0005 |
| 883 |
ABSCESS |
7 |
0.0005 |
| 884 |
ACCIDENTAL OVERDOSE |
15 |
0.0005 |
| 885 |
LYMPHOMA |
7 |
0.0005 |
| 886 |
ABNORMAL BEHAVIOUR |
19 |
0.0005 |
| 887 |
CYTOMEGALOVIRUS INFECTION |
7 |
0.0005 |
| 888 |
KNEE ARTHROPLASTY |
8 |
0.0005 |
| 889 |
COVID-19 |
65 |
0.0005 |
| 890 |
HOSPITALISATION |
58 |
0.0005 |
| 891 |
TREATMENT NONCOMPLIANCE |
21 |
0.0005 |
| 892 |
METABOLIC ACIDOSIS |
13 |
0.0005 |
| 893 |
SKIN BURNING SENSATION |
31 |
0.0005 |
| 894 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
10 |
0.0005 |
| 895 |
BLOOD COUNT ABNORMAL |
8 |
0.0005 |
| 896 |
PRODUCT DOSE OMISSION ISSUE |
73 |
0.0005 |
| 897 |
PERITONITIS |
9 |
0.0005 |
| 898 |
LIVER DISORDER |
18 |
0.0005 |
| 899 |
AGGRESSION |
22 |
0.0005 |
| 900 |
INJECTION SITE ERYTHEMA |
51 |
0.0005 |
| 901 |
MALIGNANT NEOPLASM PROGRESSION |
39 |
0.0005 |
| 902 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
18 |
0.0005 |
| 903 |
DISABILITY |
8 |
0.0005 |
| 904 |
CARDIAC ARREST |
35 |
0.0005 |
| 905 |
INJECTION SITE URTICARIA |
9 |
0.0005 |
| 906 |
ARRHYTHMIA |
20 |
0.0005 |
| 907 |
ANHEDONIA |
12 |
0.0005 |
| 908 |
HAEMATOMA |
11 |
0.0005 |
| 909 |
RESTLESSNESS |
15 |
0.0005 |
| 910 |
PULMONARY FIBROSIS |
7 |
0.0005 |
| 911 |
HEPATITIS |
10 |
0.0005 |
| 912 |
BONE MARROW FAILURE |
9 |
0.0005 |
| 913 |
PSYCHOMOTOR HYPERACTIVITY |
7 |
0.0005 |
| 914 |
UNRESPONSIVE TO STIMULI |
10 |
0.0005 |
| 915 |
HEMIPARESIS |
7 |
0.0005 |
| 916 |
NEUTROPENIA |
49 |
0.0005 |
| 917 |
TOOTH DISORDER |
9 |
0.0005 |
| 918 |
HEPATIC FAILURE |
12 |
0.0005 |
| 919 |
CHROMATURIA |
9 |
0.0005 |
| 920 |
CONVULSION |
27 |
0.0005 |
| 921 |
ACUTE MYOCARDIAL INFARCTION |
12 |
0.0005 |
| 922 |
WITHDRAWAL SYNDROME |
15 |
0.0005 |
| 923 |
CORONARY ARTERY DISEASE |
13 |
0.0005 |
| 924 |
STAPHYLOCOCCAL INFECTION |
13 |
0.0005 |
| 925 |
ENCEPHALOPATHY |
9 |
0.0005 |
| 926 |
HYPOACUSIS |
15 |
0.0005 |
| 927 |
PRESCRIBED OVERDOSE |
7 |
0.0005 |
| 928 |
BLOOD GLUCOSE INCREASED |
73 |
0.0005 |
| 929 |
RESPIRATORY DISORDER |
11 |
0.0005 |
| 930 |
DISEASE RECURRENCE |
15 |
0.0005 |
| 931 |
LUNG INFECTION |
7 |
0.0004 |
| 932 |
ABNORMAL DREAMS |
11 |
0.0004 |
| 933 |
TOOTH LOSS |
8 |
0.0004 |
| 934 |
PAIN OF SKIN |
10 |
0.0004 |
| 935 |
NEOPLASM MALIGNANT |
23 |
0.0004 |
| 936 |
ERECTILE DYSFUNCTION |
9 |
0.0004 |
| 937 |
PRODUCT PRESCRIBING ERROR |
7 |
0.0004 |
| 938 |
INJECTION SITE SWELLING |
25 |
0.0004 |
| 939 |
DEAFNESS |
9 |
0.0004 |
| 940 |
PULMONARY OEDEMA |
16 |
0.0004 |
| 941 |
NEEDLE ISSUE |
8 |
0.0004 |
| 942 |
DIABETES MELLITUS |
28 |
0.0004 |
| 943 |
PSORIASIS |
46 |
0.0004 |
| 944 |
FLUID RETENTION |
18 |
0.0004 |
| 945 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
8 |
0.0004 |
| 946 |
ANGIOEDEMA |
15 |
0.0004 |
| 947 |
PANCREATIC CARCINOMA |
11 |
0.0004 |
| 948 |
DRUG PRESCRIBING ERROR |
8 |
0.0004 |
| 949 |
NEOPLASM PROGRESSION |
12 |
0.0004 |
| 950 |
BLOOD GLUCOSE DECREASED |
17 |
0.0004 |
| 951 |
URINARY INCONTINENCE |
10 |
0.0004 |
| 952 |
OSTEONECROSIS OF JAW |
9 |
0.0004 |
| 953 |
MOOD ALTERED |
9 |
0.0004 |
| 954 |
CARDIAC DISORDER |
32 |
0.0004 |
| 955 |
OSTEONECROSIS |
12 |
0.0004 |
| 956 |
ANGINA PECTORIS |
10 |
0.0004 |
| 957 |
LUNG DISORDER |
15 |
0.0004 |
| 958 |
PANCREATITIS |
17 |
0.0004 |
| 959 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
12 |
0.0004 |
| 960 |
EXTRA DOSE ADMINISTERED |
9 |
0.0004 |
| 961 |
CARDIAC FAILURE |
25 |
0.0004 |
| 962 |
HEPATIC ENZYME INCREASED |
20 |
0.0004 |
| 963 |
FEMUR FRACTURE |
10 |
0.0004 |
| 964 |
TYPE 2 DIABETES MELLITUS |
10 |
0.0004 |
| 965 |
PSYCHOTIC DISORDER |
9 |
0.0004 |
| 966 |
PRESYNCOPE |
7 |
0.0004 |
| 967 |
RESPIRATORY ARREST |
9 |
0.0004 |
| 968 |
UNDERDOSE |
21 |
0.0004 |
| 969 |
INJECTION SITE REACTION |
20 |
0.0004 |
| 970 |
RENAL INJURY |
10 |
0.0004 |
| 971 |
DRUG EXPOSURE DURING PREGNANCY |
12 |
0.0004 |
| 972 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
10 |
0.0003 |
| 973 |
EMOTIONAL DISTRESS |
39 |
0.0003 |
| 974 |
LACTIC ACIDOSIS |
8 |
0.0003 |
| 975 |
DEVICE DISLOCATION |
12 |
0.0003 |
| 976 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
8 |
0.0003 |
| 977 |
PSORIATIC ARTHROPATHY |
9 |
0.0003 |
| 978 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
8 |
0.0003 |
| 979 |
DEVICE LEAKAGE |
7 |
0.0003 |
| 980 |
DEVICE DIFFICULT TO USE |
10 |
0.0003 |
| 981 |
CARDIO-RESPIRATORY ARREST |
10 |
0.0003 |
| 982 |
OVERDOSE |
48 |
0.0003 |
| 983 |
DEATH |
185 |
0.0003 |
| 984 |
DRUG ABUSE |
18 |
0.0003 |
| 985 |
MYOCARDIAL INFARCTION |
40 |
0.0003 |
| 986 |
MULTIPLE SCLEROSIS RELAPSE |
15 |
0.0002 |
| 987 |
TREATMENT FAILURE |
13 |
0.0002 |
| 988 |
RHABDOMYOLYSIS |
7 |
0.0002 |
| 989 |
SUICIDE ATTEMPT |
10 |
0.0002 |
| 990 |
DRUG WITHDRAWAL SYNDROME |
15 |
0.0002 |
| 991 |
NO ADVERSE EVENT |
21 |
0.0002 |
| 992 |
BREAST CANCER |
13 |
0.0001 |
| 993 |
DEVICE ISSUE |
9 |
0.0001 |
| 994 |
DRUG DEPENDENCE |
18 |
0.0001 |
| 995 |
MATERNAL EXPOSURE DURING PREGNANCY |
7 |
0.0001 |